Insomnia Pharmacological Treatment Market Research Report by Treatment (Over-the-Counter Sleep Aids and Prescription Sleep Aids) - Global Forecast to 2025 - Cumulative Impact of COVID-19
Market Statistics:
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Insomnia Pharmacological Treatment Market is expected to grow from USD 7,530.46 Million in 2020 to USD 9,863.52 Million by the end of 2025.
2. The Global Insomnia Pharmacological Treatment Market is expected to grow from EUR 6,602.85 Million in 2020 to EUR 8,648.52 Million by the end of 2025.
3. The Global Insomnia Pharmacological Treatment Market is expected to grow from GBP 5,869.95 Million in 2020 to GBP 7,688.55 Million by the end of 2025.
4. The Global Insomnia Pharmacological Treatment Market is expected to grow from JPY 803,691.64 Million in 2020 to JPY 1,052,687.61 Million by the end of 2025.
5. The Global Insomnia Pharmacological Treatment Market is expected to grow from AUD 10,935.23 Million in 2020 to AUD 14,323.14 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Insomnia Pharmacological Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Treatment, the Insomnia Pharmacological Treatment Market studied across Over-the-Counter Sleep Aids and Prescription Sleep Aids. The Over-the-Counter Sleep Aids further studied across Antihistamines, Melatonin, and Valerian Roots. The Prescription Sleep Aids further studied across Benzodiazepines, Melatonin Receptor Antagonists, Non-benzodiazepines, and Orexin Antagonists.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Insomnia Pharmacological Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Insomnia Pharmacological Treatment Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Insomnia Pharmacological Treatment Market including Aa Pharma Inc, Actavis Totowa LLC, Altimed Pharma Inc., Amneal Pharmaceuticals NY LLC, Direct_Rx, Ebb Therapeutics, Eisai Co., Ltd., Foxland Pharmaceuticals, Inc., Fresenius Kabi USA, LLC, Hospira, Inc., Ingenus Pharmaceuticals, LLC, Meda Consumer Healthcare, Inc, MEDA Pharmaceuticals, MedPointe Pharmaceuticals, Merck & Co., Inc., Micro Labs Limited, Mylan N.V., Paratek Pharmaceuticals, Inc., Pernix Therapeutics, Pfizer Inc., Pro Doc Limitee, Purdue Pharmaceuticals L.P., Remedy Repack, Sanofi S.A., Sivem Pharmaceuticals Ulc, Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceuticals Company Ltd., TriVue Pharmaceuticals, Inc., Vanda Pharmaceuticals, and Winthrop U.S..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Insomnia Pharmacological Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Insomnia Pharmacological Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insomnia Pharmacological Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insomnia Pharmacological Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Insomnia Pharmacological Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Insomnia Pharmacological Treatment Market?
6. What are the modes and strategic moves considered suitable for entering the Global Insomnia Pharmacological Treatment Market?
The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.
1. The Global Insomnia Pharmacological Treatment Market is expected to grow from USD 7,530.46 Million in 2020 to USD 9,863.52 Million by the end of 2025.
2. The Global Insomnia Pharmacological Treatment Market is expected to grow from EUR 6,602.85 Million in 2020 to EUR 8,648.52 Million by the end of 2025.
3. The Global Insomnia Pharmacological Treatment Market is expected to grow from GBP 5,869.95 Million in 2020 to GBP 7,688.55 Million by the end of 2025.
4. The Global Insomnia Pharmacological Treatment Market is expected to grow from JPY 803,691.64 Million in 2020 to JPY 1,052,687.61 Million by the end of 2025.
5. The Global Insomnia Pharmacological Treatment Market is expected to grow from AUD 10,935.23 Million in 2020 to AUD 14,323.14 Million by the end of 2025.
Market Segmentation & Coverage:
This research report categorizes the Insomnia Pharmacological Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Treatment, the Insomnia Pharmacological Treatment Market studied across Over-the-Counter Sleep Aids and Prescription Sleep Aids. The Over-the-Counter Sleep Aids further studied across Antihistamines, Melatonin, and Valerian Roots. The Prescription Sleep Aids further studied across Benzodiazepines, Melatonin Receptor Antagonists, Non-benzodiazepines, and Orexin Antagonists.
'The Asia-Pacific is projected to witness the highest growth during the forecast period'
Based on Geography, the Insomnia Pharmacological Treatment Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded the largest size in the Insomnia Pharmacological Treatment Market in 2020. On the other hand, the Asia-Pacific is expected to grow at the fastest CAGR during the forecast period.
Company Usability Profiles:
The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Insomnia Pharmacological Treatment Market including Aa Pharma Inc, Actavis Totowa LLC, Altimed Pharma Inc., Amneal Pharmaceuticals NY LLC, Direct_Rx, Ebb Therapeutics, Eisai Co., Ltd., Foxland Pharmaceuticals, Inc., Fresenius Kabi USA, LLC, Hospira, Inc., Ingenus Pharmaceuticals, LLC, Meda Consumer Healthcare, Inc, MEDA Pharmaceuticals, MedPointe Pharmaceuticals, Merck & Co., Inc., Micro Labs Limited, Mylan N.V., Paratek Pharmaceuticals, Inc., Pernix Therapeutics, Pfizer Inc., Pro Doc Limitee, Purdue Pharmaceuticals L.P., Remedy Repack, Sanofi S.A., Sivem Pharmaceuticals Ulc, Sumitomo Dainippon Pharma Co., Ltd., Takeda Pharmaceuticals Company Ltd., TriVue Pharmaceuticals, Inc., Vanda Pharmaceuticals, and Winthrop U.S..
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.
360iResearch FPNV Positioning Matrix:
The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Insomnia Pharmacological Treatment Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
360iResearch Competitive Strategic Window:
The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments
The report answers questions such as:
1. What is the market size and forecast of the Global Insomnia Pharmacological Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Insomnia Pharmacological Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Insomnia Pharmacological Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Insomnia Pharmacological Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Insomnia Pharmacological Treatment Market?
6. What are the modes and strategic moves considered suitable for entering the Global Insomnia Pharmacological Treatment Market?
1. PREFACE
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Treatment Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing stress level and physical disorders
5.1.1.2. Prevalence of chronic insomnia in adult patients
5.1.1.3. Rising awareness among patient and increasing visits to doctor regarding to insomnia
5.1.2. Restraints
5.1.2.1. Side effects associated with drugs
5.1.3. Opportunities
5.1.3.1. Development of novel products
5.1.3.2. Increase in penetration of new pharmaceuticals in developing areas
5.1.4. Challenges
5.1.4.1. Individual level stigma about insomnia in some patients
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, BY TREATMENT
6.1. Introduction
6.2. Over-the-Counter Sleep Aids
6.2.1. Antihistamines
6.2.2. Melatonin
6.2.3. Valerian Roots
6.3. Prescription Sleep Aids
6.3.1. Benzodiazepines
6.3.2. Melatonin Receptor Antagonists
6.3.3. Non-benzodiazepines
6.3.3.1. Eszopiclone
6.3.3.2. Zaleplon
6.3.3.3. Zolpidem
6.3.4. Orexin Antagonists
7. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Aa Pharma Inc
11.2. Actavis Totowa LLC
11.3. Altimed Pharma Inc.
11.4. Amneal Pharmaceuticals NY LLC
11.5. Direct_Rx
11.6. Ebb Therapeutics
11.7. Eisai Co., Ltd.
11.8. Foxland Pharmaceuticals, Inc.
11.9. Fresenius Kabi USA, LLC
11.10. Hospira, Inc.
11.11. Ingenus Pharmaceuticals, LLC
11.12. Meda Consumer Healthcare, Inc
11.13. MEDA Pharmaceuticals
11.14. MedPointe Pharmaceuticals
11.15. Merck & Co., Inc.
11.16. Micro Labs Limited
11.17. Mylan N.V.
11.18. Paratek Pharmaceuticals, Inc.
11.19. Pernix Therapeutics
11.20. Pfizer Inc.
11.21. Pro Doc Limitee
11.22. Purdue Pharmaceuticals L.P.
11.23. Remedy Repack
11.24. Sanofi S.A.
11.25. Sivem Pharmaceuticals Ulc
11.26. Sumitomo Dainippon Pharma Co., Ltd.
11.27. Takeda Pharmaceuticals Company Ltd.
11.28. TriVue Pharmaceuticals, Inc.
11.29. Vanda Pharmaceuticals
11.30. Winthrop U.S.
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Stakeholders
2. RESEARCH METHODOLOGY
2.1. Research Process
2.1.1. Define: Research Objective
2.1.2. Determine: Research Design
2.1.3. Prepare: Research Instrument
2.1.4. Collect: Data Source
2.1.5. Analyze: Data Interpretation
2.1.6. Formulate: Data Verification
2.1.7. Publish: Research Report
2.1.8. Repeat: Report Update
2.2. Research Execution
2.2.1. Initiation: Research Process
2.2.2. Planning: Develop Research Plan
2.2.3. Execution: Conduct Research
2.2.4. Verification: Finding & Analysis
2.2.5. Publication: Research Report
2.3. Research Outcome
3. EXECUTIVE SUMMARY
3.1. Introduction
3.2. Market Outlook
3.3. Treatment Outlook
3.4. Geography Outlook
3.5. Competitor Outlook
4. MARKET OVERVIEW
4.1. Introduction
4.2. Cumulative Impact of COVID-19
5. MARKET INSIGHTS
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing stress level and physical disorders
5.1.1.2. Prevalence of chronic insomnia in adult patients
5.1.1.3. Rising awareness among patient and increasing visits to doctor regarding to insomnia
5.1.2. Restraints
5.1.2.1. Side effects associated with drugs
5.1.3. Opportunities
5.1.3.1. Development of novel products
5.1.3.2. Increase in penetration of new pharmaceuticals in developing areas
5.1.4. Challenges
5.1.4.1. Individual level stigma about insomnia in some patients
5.2. Porters Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Customers
5.2.4. Bargaining Power of Suppliers
5.2.5. Industry Rivalry
6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, BY TREATMENT
6.1. Introduction
6.2. Over-the-Counter Sleep Aids
6.2.1. Antihistamines
6.2.2. Melatonin
6.2.3. Valerian Roots
6.3. Prescription Sleep Aids
6.3.1. Benzodiazepines
6.3.2. Melatonin Receptor Antagonists
6.3.3. Non-benzodiazepines
6.3.3.1. Eszopiclone
6.3.3.2. Zaleplon
6.3.3.3. Zolpidem
6.3.4. Orexin Antagonists
7. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET
7.1. Introduction
7.2. Argentina
7.3. Brazil
7.4. Canada
7.5. Mexico
7.6. United States
8. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET
8.1. Introduction
8.2. Australia
8.3. China
8.4. India
8.5. Indonesia
8.6. Japan
8.7. Malaysia
8.8. Philippines
8.9. South Korea
8.10. Thailand
9. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET
9.1. Introduction
9.2. France
9.3. Germany
9.4. Italy
9.5. Netherlands
9.6. Qatar
9.7. Russia
9.8. Saudi Arabia
9.9. South Africa
9.10. Spain
9.11. United Arab Emirates
9.12. United Kingdom
10. COMPETITIVE LANDSCAPE
10.1. FPNV Positioning Matrix
10.1.1. Quadrants
10.1.2. Business Strategy
10.1.3. Product Satisfaction
10.2. Market Ranking Analysis
10.3. Market Share Analysis
10.4. Competitor SWOT Analysis
10.5. Competitive Scenario
10.5.1. Merger & Acquisition
10.5.2. Agreement, Collaboration, & Partnership
10.5.3. New Product Launch & Enhancement
10.5.4. Investment & Funding
10.5.5. Award, Recognition, & Expansion
11. COMPANY USABILITY PROFILES
11.1. Aa Pharma Inc
11.2. Actavis Totowa LLC
11.3. Altimed Pharma Inc.
11.4. Amneal Pharmaceuticals NY LLC
11.5. Direct_Rx
11.6. Ebb Therapeutics
11.7. Eisai Co., Ltd.
11.8. Foxland Pharmaceuticals, Inc.
11.9. Fresenius Kabi USA, LLC
11.10. Hospira, Inc.
11.11. Ingenus Pharmaceuticals, LLC
11.12. Meda Consumer Healthcare, Inc
11.13. MEDA Pharmaceuticals
11.14. MedPointe Pharmaceuticals
11.15. Merck & Co., Inc.
11.16. Micro Labs Limited
11.17. Mylan N.V.
11.18. Paratek Pharmaceuticals, Inc.
11.19. Pernix Therapeutics
11.20. Pfizer Inc.
11.21. Pro Doc Limitee
11.22. Purdue Pharmaceuticals L.P.
11.23. Remedy Repack
11.24. Sanofi S.A.
11.25. Sivem Pharmaceuticals Ulc
11.26. Sumitomo Dainippon Pharma Co., Ltd.
11.27. Takeda Pharmaceuticals Company Ltd.
11.28. TriVue Pharmaceuticals, Inc.
11.29. Vanda Pharmaceuticals
11.30. Winthrop U.S.
12. APPENDIX
12.1. Discussion Guide
12.2. License & Pricing
LIST OF TABLES
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: SCORES
TABLE 49. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: BUSINESS STRATEGY
TABLE 50. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 51. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RANKING
TABLE 52. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MERGER & ACQUISITION
TABLE 53. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 54. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 55. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 56. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 57. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: LICENSE & PRICING
TABLE 1. CURRENCY CONVERSION RATES
TABLE 2. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 9. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 14. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 17. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 18. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 19. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 20. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 21. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 22. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 23. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 24. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 25. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 26. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 27. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 28. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 29. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 30. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 31. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 32. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 33. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 34. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 35. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 36. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 37. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 38. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 39. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 40. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 41. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 42. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 43. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 44. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 45. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 46. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 47. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
TABLE 48. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: SCORES
TABLE 49. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: BUSINESS STRATEGY
TABLE 50. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 51. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RANKING
TABLE 52. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MERGER & ACQUISITION
TABLE 53. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 54. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 55. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 56. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 57. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: LICENSE & PRICING
LIST OF FIGURES
FIGURE 1. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2025
FIGURE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, 2020 VS 2025 (USD MILLION)
FIGURE 27. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 28. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 36. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 38. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 50. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 62. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 63. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 64. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, BY TYPE
FIGURE 1. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: RESEARCH EXECUTION
FIGURE 3. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2020 VS 2025 (USD MILLION)
FIGURE 4. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 (USD MILLION)
FIGURE 5. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
FIGURE 6. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, 2018-2025 (USD MILLION)
FIGURE 7. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 8. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 9. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 10. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: MARKET DYNAMICS
FIGURE 11. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: PORTERS FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (%)
FIGURE 13. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2020 VS 2025 (USD MILLION)
FIGURE 14. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY TREATMENT, 2025
FIGURE 15. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OVER-THE-COUNTER SLEEP AIDS, 2020 VS 2025 (USD MILLION)
FIGURE 16. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ANTIHISTAMINES, 2020 VS 2025 (USD MILLION)
FIGURE 17. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN, 2020 VS 2025 (USD MILLION)
FIGURE 18. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY VALERIAN ROOTS, 2020 VS 2025 (USD MILLION)
FIGURE 19. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY PRESCRIPTION SLEEP AIDS, 2020 VS 2025 (USD MILLION)
FIGURE 20. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY BENZODIAZEPINES, 2020 VS 2025 (USD MILLION)
FIGURE 21. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY MELATONIN RECEPTOR ANTAGONISTS, 2020 VS 2025 (USD MILLION)
FIGURE 22. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY NON-BENZODIAZEPINES, 2020 VS 2025 (USD MILLION)
FIGURE 23. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ESZOPICLONE, 2020 VS 2025 (USD MILLION)
FIGURE 24. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZALEPLON, 2020 VS 2025 (USD MILLION)
FIGURE 25. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY ZOLPIDEM, 2020 VS 2025 (USD MILLION)
FIGURE 26. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY OREXIN ANTAGONISTS, 2020 VS 2025 (USD MILLION)
FIGURE 27. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 28. AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 30. ARGENTINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 31. BRAZIL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 32. CANADA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 33. MEXICO INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 34. UNITED STATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 35. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 36. ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 37. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 38. AUSTRALIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 39. CHINA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 40. INDIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 41. INDONESIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 42. JAPAN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 43. MALAYSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 44. PHILIPPINES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 45. SOUTH KOREA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 46. THAILAND INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 47. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
FIGURE 48. EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
FIGURE 49. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2025
FIGURE 50. FRANCE INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 51. GERMANY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 52. ITALY INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 53. NETHERLANDS INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 54. QATAR INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 55. RUSSIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 56. SAUDI ARABIA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 57. SOUTH AFRICA INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 58. SPAIN INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 59. UNITED ARAB EMIRATES INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 60. UNITED KINGDOM INSOMNIA PHARMACOLOGICAL TREATMENT MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
FIGURE 61. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
FIGURE 62. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: 360IRESEARCH MARKET SHARE ANALYSIS
FIGURE 63. GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET: COMPETITOR SWOT ANALYSIS
FIGURE 64. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL INSOMNIA PHARMACOLOGICAL TREATMENT MARKET, BY TYPE
